Saturday, December 06, 2025 | 09:39 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

DRL steps up Sputnik V supplies with second dose from Panacea Biotec

Hospital industry sources claim they want assurance on shelf life of imported vaccines

Sputnik
premium

Test tubes are seen in front of a displayed Sputnik V logo in this illustration (Photo: Reuters)

Sohini Das Mumbai
Buoyed by supplies from Panacea Biotec, Dr Reddy’s Laboratories (DRL) is now looking at liquidating the stock of around 2.6 mn Sputnik V first dose components it has.

Meanwhile, a Sputnik Light (first dose of Sputnik V) roll out can also happen soon if the Indian regulator allows. This would ensure faster roll-out of the first dose component of the Sputnik V vaccine.

DRL, the sole distributor of Sputnik V in India under an agreement with the Russian Direct Investment Fund (RDIF), had received around 3.1 mn first dose components of the Sputnik V, and about 4.5 lakh doses of